Literature DB >> 11394392

Combination use of bovine porous bone mineral, enamel matrix proteins, and a bioabsorbable membrane in intrabony periodontal defects in humans.

V Lekovic1, P M Camargo, M Weinlaender, E B Kenney, N Vasilic.   

Abstract

BACKGROUND: The purpose of this study was to evaluate the effectiveness of a combination of enamel matrix proteins (EMP), bovine porous bone mineral (BPBM), and a bioabsorbable membrane for guided tissue regeneration (GTR) as regenerative therapy for intrabony defects in humans and compare it to an open flap debridement (OFD) technique.
METHODS: Using a split-mouth design, 18 pairs of intrabony defects were treated and surgically reentered 6 months after the initial surgery. Experimental sites were treated with EMP, grafted with BPBM, and received a collagen/polylactic acid membrane for GTR. Control sites were treated with OFD. The primary outcomes evaluated in the study included probing depth resolution, clinical attachment gain, and bony defect fill.
RESULTS: Preoperative probing depths, attachment levels, and intraoperative bone measurements were similar for the experimental and control groups. Postsurgical measurements taken at 6 months revealed a significantly greater reduction in probing depth in the experimental group (4.95+/-1.52 mm on buccal sites and 4.74+/-1.47 mm on lingual sites) when compared to the control group (2.83+/-0.83 mm on buccal sites and 2.90+/-0.91 mm on lingual sites). The experimental sites also presented with significantly more attachment gain (3.89+/-1.16 mm on buccal sites and 3.78+/-1.14 mm on lingual sites) than the control sites (1.52+/-0.83 mm on buccal sites and 1.48+/-0.78 mm on lingual sites). Surgical reentry of the treated defects revealed a significantly greater amount of defect fill in favor of the experimental group (4.76+/-1.36 mm on buccal sites and 4.81+/-1.37 mm on lingual sites) as compared to the control group (1.78+/-0.92 mm on buccal sites and 1.67+/-0.90 mm on lingual sites).
CONCLUSIONS: The results of this study indicate that a combination technique including BPBM, EMP, and GTR results in better clinical resolution of intrabony defects than treatment with OFD. Differences observed were both statistically and clinically significant. The exact role of each of the 3 technique components in achieving the clinical improvement observed in this study remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11394392     DOI: 10.1902/jop.2001.72.5.583

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  5 in total

1.  Use of platelet-rich plasma in periodontal surgery--a prospective randomised double blind clinical trial.

Authors:  L Harnack; R H Boedeker; I Kurtulus; S Boehm; J Gonzales; J Meyle
Journal:  Clin Oral Investig       Date:  2008-09-03       Impact factor: 3.573

2.  A comparative evaluation of bovine-derived xenograft (Bio-Oss Collagen) and type I collagen membrane (Bio-Gide) with bovine-derived xenograft (Bio-Oss Collagen) and fibrin fibronectin sealing system (TISSEEL) in the treatment of intrabony defects: A clinico-radiographic study.

Authors:  Deepthi Palachur; K V Prabhakara Rao; K Raja V Murthy; D Trinath Kishore; M Narendra Reddy; Anitha Bhupathi
Journal:  J Indian Soc Periodontol       Date:  2014-05

Review 3.  Regeneration of the Periodontal Apparatus in Aggressive Periodontitis Patients.

Authors:  Zvi Artzi; Shiran Sudri; Ori Platner; Avital Kozlovsky
Journal:  Dent J (Basel)       Date:  2019-03-08

4.  In vivo and in vitro evaluation of an Acetobacter xylinum synthesized microbial cellulose membrane intended for guided tissue repair.

Authors:  Péricles Nóbrega Mendes; Sheila Canevese Rahal; Oduvaldo Câmara Marques Pereira-Junior; Viciany Erique Fabris; Sara Lais Rahal Lenharo; João Ferreira de Lima-Neto; Fernanda da Cruz Landim-Alvarenga
Journal:  Acta Vet Scand       Date:  2009-03-24       Impact factor: 1.695

5.  Biocompatibility of three bioabsorbable membranes assessed in FGH fibroblasts and human osteoblast like cells culture.

Authors:  Michelle Pereira Costa Mundim Soares; Paulo Vinícius Soares; Analice Giovani Pereira; Camilla Christian Gomes Moura; Priscila Barbosa Ferreira Soares; Lucas Zago Naves; Denildo de Magalhães
Journal:  Head Face Med       Date:  2014-08-06       Impact factor: 2.151

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.